GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $13,013,000 | -11.9% | 236,158 | +0.9% | 0.02% | -16.7% |
Q2 2020 | $14,772,000 | +542.5% | 234,158 | +420.4% | 0.02% | +350.0% |
Q1 2020 | $2,299,000 | -31.9% | 45,000 | +5.9% | 0.00% | 0.0% |
Q4 2019 | $3,378,000 | -0.6% | 42,501 | -39.3% | 0.00% | 0.0% |
Q3 2019 | $3,397,000 | -25.6% | 70,000 | -19.4% | 0.00% | -20.0% |
Q2 2019 | $4,566,000 | +67.5% | 86,800 | +68.5% | 0.01% | +66.7% |
Q1 2019 | $2,726,000 | +87.1% | 51,500 | +45.1% | 0.00% | +50.0% |
Q4 2018 | $1,457,000 | +411.2% | 35,500 | +373.3% | 0.00% | – |
Q3 2018 | $285,000 | -15.9% | 7,500 | 0.0% | 0.00% | – |
Q2 2018 | $339,000 | -54.1% | 7,500 | -51.0% | 0.00% | -100.0% |
Q1 2018 | $739,000 | -16.5% | 15,300 | -32.0% | 0.00% | 0.0% |
Q4 2017 | $885,000 | – | 22,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |